"Urgent Call from WHO: South-East Asia Faces Escalating Threat of Antimicrobial Resistance Jeopardizing Medical Progress"

Spread the Message

Read Time:3 Minute, 19 Second

WHO has issued a strong warning about the escalating threat of antimicrobial resistance (AMR) in the South-East Asia region, urging urgent and coordinated action to prevent severe setbacks in medical progress. The latest WHO Global Antimicrobial Resistance Surveillance Report highlights that the South-East Asia region is among the most affected globally, with a high prevalence of drug-resistant infections jeopardizing decades of advancements in treating infectious diseases. This growing resistance threatens to undermine essential health services and calls for enhanced governance, financing, innovation, and integration of AMR strategies into broader health systems.

Key Findings on AMR in South-East Asia

Antimicrobial resistance occurs when bacteria, viruses, fungi, and parasites no longer respond to medicines designed to kill or inhibit them, making infections harder to treat. WHO reports that in the South-East Asia region, around 1 in 3 infections are resistant to commonly used antibiotics, making it a hotspot for this global health crisis. Factors such as widespread irrational prescribing, self-medication, easy access to antimicrobials without proper regulation, and the circulation of substandard or counterfeit drugs exacerbate the problem. Additionally, the rapid intensification of food production and weak healthcare infrastructure contribute to the region’s vulnerability to AMR.

The 2025 WHO report reveals that drug-resistant gonorrhea, tuberculosis, and other bacterial infections are rising in South-East Asia, posing a serious risk. Multi-drug resistant tuberculosis (MDR-TB), for example, has worrying prevalence rates, complicating treatment and control efforts. The problem extends beyond human health, affecting veterinary and environmental sectors, necessitating multisectoral collaboration under the One Health approach.

Expert Perspectives and Regional Responses

Dr. Catharina Boehme, Officer-in-Charge for WHO South-East Asia, emphasized during World AMR Awareness Week 2025 that “drug-resistant infections are undermining decades of medical progress and jeopardizing essential health services across the region.” She urged governments and stakeholders to adopt the recently endorsed Regional Roadmap on AMR (2025–2030), which focuses on stronger governance, increased financing, innovation, and integration of AMR efforts with overall health systems to stem the tide of resistance.

Independent experts highlight that the region’s high infectious disease burden combined with social and economic factors amplifies AMR’s impact. Dr. B. Sihombing, a public health researcher specializing in AMR, notes that “addressing antimicrobial resistance in South-East Asia requires robust surveillance, public education, regulation of antimicrobial use, and investment in new diagnostics and treatments.”

Public Health Implications and Limitations

The rising AMR threatens to roll back medical advancements such as effective surgeries, cancer chemotherapy, and organ transplants, which rely heavily on effective antibiotics to prevent and treat infections. If unchecked, it could lead to a scenario resembling the pre-antibiotic era, where common infections become life-threatening. This poses a significant public health challenge requiring urgent multisectoral cooperation.

While the Regional Roadmap and WHO initiatives aim to accelerate progress, there are limitations including inconsistent data collection, variable healthcare capacity among countries, and the ongoing challenge of changing entrenched prescribing behaviors. Additionally, economic constraints and competing health priorities may impact implementation effectiveness.

Practical Takeaways for Readers

For general readers, the AMR threat underscores the importance of responsible antibiotic use: only taking antibiotics when prescribed by a qualified healthcare professional, completing the full course of treatment, and avoiding self-medication. Public awareness and health literacy are crucial in reducing misuse and slowing resistance. Moreover, preventive measures such as vaccination, proper hygiene, and infection control remain key strategies to reduce infection incidence and thereby antibiotic demand.

Medical Disclaimer and References

Medical Disclaimer: This article is for informational purposes only and should not be considered medical advice. Always consult with qualified healthcare professionals before making any health-related decisions or changes to your treatment plan. The information presented here is based on current research and expert opinions, which may evolve as new evidence emerges.